VA
AVNS

Vident Advisory’s Avanos Medical AVNS Stock Holding History

Vident Advisory’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$234K Sell
16,687
-35,362
-68% -$476K ﹤0.01% 1612
2025
Q4 		$585K Buy
+52,049
New +$596K 0.01% 1086

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Vident Advisory's AVNS Position: Q1 2026 in Review

Vident Advisory reduced its Avanos Medical (AVNS) stake by 68% in Q1 2026, selling an estimated $476K and leaving 16,687 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Vident Advisory first reported a position in AVNS in Q4 2025 and has held it in 2 quarters since. The position peaked at $585K in Q4 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Vident Advisory held 16,687 shares of Avanos Medical worth $234K as of Q1 2026.
  • Vident Advisory sold 35,362 Avanos Medical shares in Q1 2026, an estimated $476K.
  • Avanos Medical made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1612 holding.
  • Vident Advisory first reported a position in Avanos Medical in Q4 2025 and has held it in 2 quarters since.
  • Vident Advisory's Avanos Medical position peaked at $585K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.